Medication Guide for Brigatinib/Brigatinib: Key Dosing Precautions

Brigatinib/Brigatinib (Brigatinib) is a new dual inhibitor mainly used to treat ALK-positive non-small cell lung cancer. When using this drug, patients need to pay special attention to certain precautions to ensure its effectiveness and safety.

First, the starting dose of brigatinib is usually 90 mg per day for 7 days. If no serious side effects or intolerance occur, the dose will be adjusted to 180 mg per day after 7 days. This is important because proper dosage adjustment ensures effective concentrations of the drug in the body while reducing the risk of adverse reactions. Secondly, when taking brigatinib, patients should swallow the tablet whole and not crush or chew it to ensure slow release and stable absorption of the drug in the body. Additionally, brigatinib can be taken with or without food, providing patients with dosing flexibility.

During medication, patients should avoid ingesting foods and drugs that may affect the efficacy of brigatinib, such as grapefruit, ketoconazole, rifampicin, and phenytoin. At the same time, alcohol may also affect the metabolism and efficacy of brigatinib, so you should avoid drinking alcohol while taking the drug. In addition to the above dosage instructions, patients also need to pay close attention to their physical condition. Brigatinib can cause a range of side effects, such as vision problems, nausea, diarrhea, fatigue, cough and high blood pressure. If you have trouble breathing, chest pain, severe cough, throat swelling, or other serious adverse reactions, you should contact your doctor immediately and seek medical help.

Finally, before using brigatinib, patients should fully inform their doctors about their history of drug allergies, other drugs they are taking, and other diseases they suffer from, so that doctors can provide more accurate medication guidance.